Artia Global Partners LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $517 Billion distributed in 46 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $98.7B, Eli Lilly & CO with a value of $83.8B, Merck & Co., Inc. with a value of $54.8B, Viking Therapeutics, Inc. with a value of $24B, and Astrazeneca PLC with a value of $14.9B.
Examining the 13F form we can see an increase of $19.8B in the current position value, from $498B to 517B.
Artia Global Partners LP is based out at Miami, FL
Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.